Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
28m
on MSN
Novo Nordisk's new CagriSema study to focus on dose escalation and trial length
Novo Nordisk on Wednesday said its new trial of its next-generation obesity drug candidate CagriSema will look at dose ...
17m
on MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
25m
on MSN
Wegovy obesity drug sales more than double but set to slow
Sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Places global staff on leave
Suspends parcels from China
Wins Senate committee vote
Plans to take over Gaza
Judge blocks executive order
RFK Jr. clears Senate panel
Arrested on multiple charges
Offers to jail US criminals
Sued by former nanny
All 67 bodies recovered
Spiritual leader dies
Baby elephant at OR Zoo
To launch streaming service
Announces death of mother
Neo-Nazi leader convicted
Sweden school shooting
Suspended 10 games
Atmospheric river slams CA
US begins migrant flights
Mimics moon’s gravity
Confirmed as VA secretary
FBI agents sue DOJ
To cut up to 7,000 jobs
US job openings fall
Adds surcharge to eggs
Key Bridge design unveiled
FireAid raises over $100M
Related topics
Novo Nordisk
weight loss
Feedback